ARS Pharmaceuticals' Neffy Launch Could Be A Hit For Severe Allergic Reactions
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions. See why SPRY stock is a Buy.
Ibj.com18h
Roche gets FDA clearance for test of emerging cardiovascular disease risk
Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.
FiercePharma18h
With recent launches and more to come, Amgen's biosimilar business is trending up
After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...
usaherald1d
Battle at the Border: Drug Cartels Use Kamikaze Drones to Target U.S. Border Patrol
Mexican drug cartels are ramping up their assault on U.S. Border Patrol agents by employing kamikaze drones and explosives.
With FDA approval, Genentech turns eye implant's focus to diabetes
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Business Wire1d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
FiercePharma1d
Supernus' 4th try proves the charm with long-awaited FDA approval for Parkinson's infusion pump Onapgo
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
Trump’s China tariffs are likely to drive up drug prices and spur shortages
President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is l ikely to drive up the cost of generic ...
Supernus Gets FDA Approval of Onapgo Device for Parkinson's Disease
Supernus Pharmaceuticals has won Food and Drug Administration approval for its Onapgo device to treat patients with Parkinson's disease.
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.
Mexican drug cartels plan attacks on Border Patrol agents with kamikaze drones and other explosives to fight US crackdown
Federal agents working the border are also advised to “carry proper equipment” at all times, including first-aid kids, tourniquets and body armor. The memo also notes that rifles ...
Counter-drug sea drones utilized by Navy as Trump ramps up military resources at the border
The Navy has launched a new operation to interdict drug smugglers by sea that will rely on autonomous sea drones as President ...